Phase 3, Randomized, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM) - ALUMMINATE RRMM

Project: Research

Project Details

StatusActive
Effective start/end date20/05/24 → 19/05/26

Keywords

  • Clinical Trials
  • CA058-1019